HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 286-297

  Wijayalath, Wathsala ^a   Danner, Rebecca ^a   Kleschenko, Yuliya ^a   Majji, Sai ^a   Villasante, Eileen Franke ^a   Richie, Thomas L ^a   Brumeanu, Teodor Doru ^b   David, Chella S ^c   Casares, Sofia ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQ6 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ERYTHROCYTE; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOCRIT; HLA SYSTEM; HOST PARASITE INTERACTION; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; IRRADIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPOROZOITE; STRAIN IDENTIFICATION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 84890820495     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00272-13     Document Type: Article

References (60)

1. Murray CJL, Rosenfeld C, Lim SS, Andrews K, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431. http://dx.doi.org/10.1016/S0140-6736(12)60034-8.
2. Stanway RR, Mueller N, Zobiak B, Graewe S, Froehlke U, Zessin PJ, Aepfelbacher M, Heussler VT. 2011. Organelle segregation into Plasmodium liver stage merozoites. Cell. Microbiol. 13:1768-1782. http://dx.doi.org/10.1111/j.1462-5822.2011.01657.x.
3. Casares S, Richie TL. 2009. Immune evasion by malaria parasites: a challenge for vaccine development. Curr. Opin. Immunol. 21:321-330. http://dx.doi.org/10.1016/j.coi.2009.05.015.
4. Nogaro SI, Hafalla JC, Walther B, Remarque EJ, Tetteh KK, Conway DJ, Riley EM, Walther M. 2011. The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission. PLoS One 6:e25582. http://dx.doi.org/10.1371/journal.pone.0025582.
5. Rothbard JB, Gefter ML. 1991. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9:527-565. http://dx.doi.org/10.1146/annurev.iy.09.040191.002523.
6. Ma CS, Deenick EK, Batten M, Tangye SG. 2012. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209:1241-1253. http://dx.doi.org/10.1084/jem.20120994.
7. Issa F, Robb RJ, Wood KJ. 2013. The where and when of T cell regulation in transplantation. Trends Immunol. 34:107-113. http://dx.doi.org/10.1016/j.it.2012.11.003.
8. Surls J, Nazarov-Stoica C, Kehl M, Casares S, Brumeanu TD. 2010. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine 28:7319-7330. http://dx.doi.org/10.1016/j.vaccine.2010.08.074.
9. Maizels RM, Smith KA. 2011. Regulatory T cells in infection. Adv. Immunol. 112:73-136. http://dx.doi.org/10.1016/B978-0-12-387827-4.00003-6.
10. Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR. 2010. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 6:e1001221. http://dx.doi.org/10.1371/journal.ppat.1001221.
11. Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, Duan X, Chou B, Ishida H, Aramaki A, Shen J, Ishii KJ, Coban C, Akira S, Takeda K, Yasutomo K, Torii M, Himeno K. 2008. TLR9 signaling for immune evasion by activating regulatory T cells. J. Immunol. 180:2496-2503.
12. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, Flavell RA, de Souza JB, Riley EM. 2008. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 4:e1000004. http://dx.doi.org/10.1371/journal.ppat.1000004.
13. Wu Y, Wang QH, Zheng L, Feng H, Liu J, Ma SH, Cao YM. 2007. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Exp. Parasitol. 115:301-304. http://dx.doi.org/10.1016/j.exppara.2006.09.015.
14. Long TT, Nakazawa S, Onizuka S, Huaman MC, Kanbara H. 2003. Influence of CD4+ CD25+ T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33:175-183. http://dx.doi.org/10.1016/S0020-7519(02)00261-8.
15. Randall LM, Amante FH, McSweeney KA, Zhou Y, Stanley AC, Haque A, Jones MK, Hill GR, Boyle GM, Engwerda CR. 2008. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect. Immun. 76:3312-3320. http://dx.doi.org/10.1128/IAI.01475-07.
16. Vigario AM, Gorgette O, Dujardin HC, Cruz T, Cazenave PA, Six A, Bandeira A, Pied S. 2007. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int. J. Parasitol. 37:963-973. http://dx.doi.org/10.1016/j.ijpara.2007.01.004.
17. Cambos M, Bélanger B, Jacques A, Roulet A, Scorza T. 2008. Natural regulatory (CD4+ CD25+ FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int. J. Parasitol. 38:229-238. http://dx.doi.org/10.1016/j.ijpara.2007.07.006.
18. Nie CQ, Bernard NJ, Schofield L, Hansen DS. 2007. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect. Immun. 75:2275-2282. http://dx.doi.org/10.1128/IAI.01783-06.
19. Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno K, Kishihara K, Tsukumo S, Yasutomo K. 2004. Escape of malaria parasites from host immunity requires CD4+CD25+regulatory T cells. Nat. Med. 10:29-30. http://dx.doi.org/10.1038/nm975.
20. Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM. 2011. IL-2 contributes to maintaining a balance between CD4+ Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of bloodstage malaria infection. J. Immunol. 186:4862-4871. http://dx.doi.org/10.4049/jimmunol.1003777.
21. Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, Edele F, de Souza JB, Sinden RE, Gilbert SC, Riley EM, Hill AV. 2005. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23:287-296. http://dx.doi.org/10.1016/j.immuni.2005.08.006.
22. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, Deininger S, Lawrence E, Ngwa-Amambua A, Jayasooriya S, Cheeseman IH, Gomez-Escobar N, Okebe J, Conway DJ, Riley EM. 2009. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 5:e1000364. http://dx.doi.org/10.1371/journal.ppat.1000364.
23. Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey NM, Plebanski M. 2009. Parasitedependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 5:e1000402. http://dx.doi.org/10.1371/journal.ppat.1000402.
24. Weinbaum FI, Evans CB, Tigelaar RE. 1976. Immunity to Plasmodium berghei yoelii in mice. I. The course of infection in T cell and B cell deficient mice. J. Immunol. 117:1999-2005.
25. Spence PJ, Langhorne J. 2012. T cell control of malaria pathogenesis. Curr. Opin. Immunol. 24:444-448. http://dx.doi.org/10.1016/j.coi.2012.05.003.
26. Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, de Vries RR, David CS, Ottenhoff TH. 1998. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95:10797-10802. http://dx.doi.org/10.1073/pnas.95.18.10797.
27. DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. 2002. Human like immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J. Infect. Dis. 185:1754-1760. http://dx.doi.org/10.1086/340828.
28. Taneja V, David CS. 2010. Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol. Rev. 233:62-78. http://dx.doi.org/10.1111/j.0105-2896.2009.00858.x.
29. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC.
30. Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, Belunis C, Bolin DR, Arceo R, Campbell R, Falcioni F, Vidović D, Hammer J, Nagy ZA. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183:2635-2644. http://dx.doi.org/10.1084/jem.183.6.2635.
31. Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, David CS. 2008. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J. Immunol. 181:2869-2877.
32. Das P, Drescher KM, Geluk A, Bradley DS, Rodriguez M, David CS. 2000. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum. Immunol. 61:279-289. http://dx.doi.org/10.1016/S0198-8859(99)00135-4.
33. Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. 1997. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100:2227-2234.
34. Strauss G, Vignali DA, Schönrich G, Hämmerling GJ. 1994. Negative and positive selection by HLA-DR3 (DRw17) molecules in transgenic mice. Immunogenetics 40:104-108.
35. Mangalam AK, Rajapopalan G, Taneja V, David CS. 2008. HLA class II transgenic mice mimic human inflammatory diseases. Adv. Immunol. 97:65-147. http://dx.doi.org/10.1016/S0065-2776(08)00002-3.
36. Danner R, Chaudhari S, Rosenberger J, Surls J, Richie TL, Brumeanu TD, Casares S. 2011. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 6:e19826.
37. Limbach K, Aguiar J, Gowda K, Patterson N, Abot E, Sedegah M, Sacci J, Richie T. 2011. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates. Malar. J. 10:65. http://dx.doi.org/10.1186/1475-2875-10-65.
38. Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TD. 2002. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat. Immunol. 3:383-391. http://dx.doi.org/10.1038/ni770.
39. van der Heyde HC, Huszar D, Woodhouse C, Manning DD, Weidanz WP. 1994. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J. Immunol. 152:4557-4562.
40. Soulard V, Roland J, Sellier C, Gruner AC, Leite-de-Moraes M, Franetich JF, Rénia L, Cazenave PA, Pied S. 2007. Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells. Infect. Immun. 75:2511-2522. http://dx.doi.org/10.1128/IAI.01818-06.
41. Morgado MG, Cam P, Gris-Liebe C, Cazenave PA, Jouvin-Marche E. 1989. Further evidence that BALBrc and C57BLr6 g 2a genes originate from distinct isotypes. EMBO J. 8:3245-8251.
42. Jouvin-Marche E, Morgado MG, Leguern C, Voegtle D, Bonhomme F, Cazenave PA. 1989. The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29:92-97. http://dx.doi.org/10.1007/BF00395856.
43. Merrick CJ, Duraisingh MT. 2010. Epigenetics in Plasmodium: what do we really know? Eukaryot. Cell 9:1150-1158. http://dx.doi.org/10.1128/EC.00093-10.
44. Shear HL, Grinberg L, Gilman J, Fabry ME, Stamatoyannopoulos G, Goldberg DE, Nagel RL. 1998. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 92:2520-2526.
45. Steinhardt LC, Magill AJ, Arguin PM. 2011. Malaria chemoprophylaxis for travelers to Latin America. Am. J. Trop. Med. Hyg. 85:1015-1024. http://dx.doi.org/10.4269/ajtmh.2011.11-0464.
46. Belnoue E, Voza T, Costa FT, Grüner AC, Mauduit M, Rosa DS, Depinay N, Kayibanda M, Vigário AM, Mazier D, Snounou G, Sinnis P, Rénia L. 2008. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 181:8552-8558.
47. Epstein JE, Giersing B, Mullen G, Moorthy V, Richie TL. 2007. Malaria vaccines: are we getting closer? Curr. Opin. Mol. Ther. 9:12-24.
48. Lim HW, Hillsamer P, Banham AH, Kim CH. 2005. Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175:4180-4183. http://www.jimmunol.org/content/175/7/4180.long.
49. Iikuni N, Lourenço EV, Hahn BH, La Cava A. 2009. Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 183:1518-1522. http://dx.doi.org/10.4049/jimmunol.0901163.
50. Kumar S, Miller LH. 1990. Cellular mechanisms in immunity to blood stage infection. Immunol. Lett. 25:109-114. http://dx.doi.org/10.1016/0165-2478(90)90100-5.
51. Clark IA, Allison AC. 1974. Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature 252:328-329. http://dx.doi.org/10.1038/252328a0.
52. Gourraud PA, Boyer JF, Barnetche T, Abbal M, Cambon-Thomsen A, Cantagrel A, Constantin A. 2006. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum. 54:593-599. http://dx.doi.org/10.1002/art.21630.
53. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. 1992. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117:801-806. http://dx.doi.org/10.7326/0003-4819-117-10-801.
54. Diggs CL, Osler AG. 1969. Humoral immunity in rodent malaria. II. Inhibition of parasitemia by serum antibody. J. Immunol. 102:298-305.
55. Golenser JL, Spira DT, Zuckerman A. 1975. Neutralizing antibody in rodent malaria. Trans. R. Soc. Trop. Med. Hyg. 69:251-258. http://dx.doi.org/10.1016/0035-9203(75)90164-9.
56. Wykes MN, Liu XQ, Beattie L, Stanisic DI, Stacey KJ, Smyth MJ, Thomas R, Good MF. 2007. Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog. 3:e96. http://dx.doi.org/10.1371/journal.ppat.0030096.
57. Wykes MN, Liu XQ, Jiang S, Hirunpetcharat C, Good MF. 2007. Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function. Immunol. 179:3982-3987.
58. May J, Meyer CG, Kun JF, Lell B, Luckner D, Dippmann AK, Bienzle U, Kremsner PG. 1999. HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families. J. Infect. Dis. 179:1042-1045. http://dx.doi.org/10.1086/314661.
59. Osafo-Addo AD, Koram KA, Oduro AR, Wilson M, Hodgson A, Rogers WO. 2008. HLA-DRB1*04 allele is associated with severe malaria in northern Ghana. Am. J. Trop. Med. Hyg. 78:251-255.
60. Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Looareesuwan S, Tokunaga K. 2005. Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients. Jpn. J. Infect. Dis. 58:25-28.